Would you treat regional nodes in a patient with complete pathologic response on axillary dissection after neoadjuvant chemo for isolated axillary recurrence?
Initial presentation was stage 1 treated with lumpectomy and whole breast radiation.
Answer from: Radiation Oncologist at Academic Institution
I would treat, in these cases. In terms of volumes, it depends on the time from the first course of RT.
If >5 years from RT, I tend to retreat nodes and breast/chest giving 50/25 to nodal regions and 45/25 to breast/chest wall.
If <5 years, I consider treating regional nodes (axilla, SCV) on...
Answer from: Radiation Oncologist at Community Practice
For a stage 1 patient treated with BCT and SLNB, isolated axillary recurrence is most likely a rare manifestation of false-negative sentinel node (2-3%). The timeline for this recurrence is most likely a function of phenotype with delayed recurrence in ER-positive disease. In the modern era, whether...